Sandoz Asks High Court To Toss Fed. Circ. Allergan Ruling
Sandoz Inc. has called upon the U.S. Supreme Court to reverse a Federal Circuit decision upholding the validity of an Allergan Inc. patent for the glaucoma drug Combigan, arguing the panel...To view the full article, register now.
Already a subscriber? Click here to view full article